On March 12, 2026, Indivior Pharmaceuticals, Inc. announced its intention to offer $400 million in convertible senior notes due 2031. The offering is aimed at qualified institutional buyers and includes a 30-day option for additional notes. Proceeds will be used for debt repayment and share repurchases.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.